The GLP-1 Pill Era Starts Now: Oral Drugs, Real Coverage
Orforglipron delivers ~12% weight loss, and Medicare now covers GLP-1 pills for older adults at about $50 a month — here is who qualifies.
Browse the latest Tikva reporting, guides, and practical explanations.
Orforglipron delivers ~12% weight loss, and Medicare now covers GLP-1 pills for older adults at about $50 a month — here is who qualifies.
The difference is not the model. It is what the AI is allowed to do.
After the July hold, HYSA and brokerage cash-sweep yields keep slipping. Here's where idle cash actually belongs now — and which brokers still pay under 1%.
Expensive stocks and a Bitcoin drubbing are the exact setup that triggers panic selling. Pre-commitment rules can stop it.
The profits are real and the multiples are rich. What Q2 2026's 23% growth and a stretched valuation mean for the money you put to work now.
After the Fed's July hold, cash still pays 4–5% and mortgages stay sticky — here's how to lock in yields and where refis finally pencil out.
The viral rule sets up the very collapse it’s meant to prevent. Recovery science points to a stronger kind of discipline.
New studies from Stanford, the ADA, and Cell Press quantify the lean tissue these drugs shed — and resistance training plus protein is the practical fix.
Self-guided wellness apps lose the vast majority of users within two weeks. The 2026 evidence reconfirms a decade-old finding: to beat burnout, change the job — not the app.
With the FOMC ~87% likely to hold at 3.50%-3.75% on July 29 and two cuts coming later this year, top cash accounts still pay near 4% — but that edge won't survive the next rate move.